Major depressive disorder is a chronic and invalidating psychiatric illness and is associated with a greater risk of suicidal behaviors. In recent decades many data have supported a biological link between depressive states and inflammation. Pro-inflammatory cytokines have been found to rise, first of all TNF-α and IL-6. Suicidal behaviors have been consistently associated with increased levels of IL-6 and decreased levels of IL-2. The aim of this review is to investigate the relationship between inflammatory markers in depressed patients with or without suicidal attempts compared to healthy controls.
Introduction
Major depressive disorder (MDD) is a chronic and invalidating psychiatric illness leading to both social and occupational disability. [1] [2] [3] MDD patients show a greater risk of suicidal behaviors than healthy controls (HC). [4] [5] [6] [7] [8] Even if suicidal behavior has been classified as a separate diagnosis in the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 1 suicide is often associated with co-morbid psychiatric disorders. For these reasons, death by suicide may be avoided following some suicide prevention strategies; 9 for systematic review and meta-analysis see Brezo et al. 10 and Arsenault-Lapierre et al. 11 Inflammation and stressor mediators leading to excitotoxicity and oxidative damage seem to play a critical role in the pathophysiology of MDD. Different cytokines have been identified as potentially relevant in the understanding of the link between mood disorders and suicidality. In fact, untreated depressed patients have been found to present an imbalance among pro-inflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-2 (IL-2), interleukin-6 (IL-6), interferon-γ (IFN-γ) and tumour necrosis factor-α (TNF-α). [12] [13] [14] In addition, various immunomodulators have been used to treat subclinical symptoms of depression, such as pain and fatigue, and sexual, bladder and bowel dysfunctions. 15 A family history of suicide is considered a risk and a predictive factor of suicidality in offspring. Contrary to suicidal behaviour, suicidal thoughts do not seem to be directly linked to a family history of suicidal ideation. 16, 17 Genetic studies have also tried to build a solid theoretical basis on gene-related aspects of suicide. Particular attention has been given to the gene encoding for tryptophan hydroxylase and monoamine oxidase A; 18, 19 for a review see Brezo et al. 20 Early-life adversities (ELA) are considered as important lifetime risks for suicidal behaviour. In fact, recent research has suggested a link between poor parent-child attachment and maladjustment in the parental role on one side, and childhood abuse on the other. 21, 22 Altered blood levels of serotonin seem to underlie depressive and suicide risk factors. Coupling postmortem binding studies and in vivo studies using positron emission tomography highlighted altered 5-hydroxytryptamine 1A and 2A (5HT1A, 5HT2A) receptor availability in suicidal brains, suggesting that insufficient serotonin levels in certain areas of the brain may be linked to suicidality. 4, 5, 23 Serotonin variation has also been considered specific to suicidal behaviour, but this alteration shows only a partial overlapping in those with depressed brains. 24, 25 In addition, it has been found that different serotoninergic genes contribute jointly to increase the risk for depression and suicidal behaviours. 26, 27 Moreover, a lower serotoninergic neurotransmission has been associated with behaviour related to suicide attempts, such as impulsive and aggressive traits, irrespective of other psychiatric conditions. Variations in serotonin levels are associated with the onset of depressive and suicidal symptoms in euthymic individuals who have had previous depressive episodes, and in patients at higher risk for developing depression. 28, 29 Stressors derived from different origins, such as physical, emotional or hormonal stimuli, physiologically activate the same pathway of polyamine, named the polyamine stress response system. Protein levels of several components of the polyamine are altered in the cortical and subcortical brain regions in patients who had completed suicide and in psychiatric patients dead from other causes. 30, 31 Primate models of depression suggest that stress may induce a modification in gene expression, leading to alterations of spermidine and spermine N1-acetyltransferase (SAT1), wich is considered the rate-limiting enzyme in the catabolism of polyamines. SAT1 has been found to be decreased in the brain cortex of suicide completers, and has been considered a peripheral biomarker of suicidality. [32] [33] [34] In recent decades many data have supported a biological link between depressive states and inflammation. An increase of pro-inflammatory cytokines have been highlighted, mainly of TNF and IL-6. [35] [36] [37] Moreoveor, patients undergoing therapy with IFN-α have been found to often develop mood depression. 38 Several reports show an association between suicidal behaviour and inflammatory cytokines even in the absence of depressive mood. Suicidal behaviour has been consistently associated with increased levels of IL-6 and decreased levels of IL-2. Decreased levels of vascular endothelial growth factor (VEGF) and increased levels of quinolonic and kinurenic acids have also been described in suicidal depressed patients. 39, 40 A higher peripheral inflammatory chemokine concentration has been reported in individuals with MDD and suicidal ideation than in those without suicidal ideation. 41, 42 Moreover, some authors reported data about the relationship among alexithymia, suicidal ideation and C-reactive protein, 43 and data regarding the effects of antidepressants on cytokine concentrations (for a review see De Berardis et al. 44 ).
With respect to GABAergic signaling, it seems that the genes encoding GABA type A receptors subunits and their associated binding proteins may be be upregulated in the hippocampus and in the prefrontal and anterior cingulate cortices of suicidal depressed patients. 45, 46 For these reasons, agents acting on the glutamatergic way are considered rapid-response antidepressants, useful in the treatment of both depressive mood and acute suicidal ideation. 47, 48 Many studies have analysed the role of astrocytes in psychopathology. In animal models of depression, impaired glial functions have been reported. 49, 50 Postmortem brain studies indicated a decreased glial cell count in the cortical grey matter of depressed patients 51 and hypertrophied astrocytes in the cortical white matter of depressed patients who died by suicide. 52 Expression gene studies have focused on the expression of connexin 30 (CX30) and connexin 43 (CX43), two proteins working as gap junctions and present almost only in astrocyte cells. In animal studies conducted on mice, CX30 and CX43 have shown altered reactivity to novel environment and they have been related to changes in brain neurotransmitters, including serotonin. 53, 54 In individuals attempting and/or completing suicide, evidence of hypothalamus pituitary adrenal (HPA) axis disfunction has been found. Postmortem studies of suicide completers revealed an increased corticotropin-releasing hormone (CRH) activity in the paraventricular nucleus, [55] [56] [57] an over-expression of CRH in the cerebrospinal fluid (CSF), 58 fewer CRH-binding sites in the frontal cortex, decreased glucocorticoid receptor expression in the hippocampus and increased levels of pro-opiomelanocortin (POMC) in the pituitary gland. 59, 60 In addition, suicide completers show increased adrenal glands weight and adrenocortical hypertrophy. Studies on relatives of suicide attempters highlighted an altered HPA axis response as well. [61] [62] [63] Brain-derived neurotrophic factor (BDNF) was found to be under-expressed by hyper-methylation in stressful situations in studies involving suicide completers. Methylation studies in hippocampal cells taken from patients who died as complete suiciders and who had history of ELA show that ELA was associated with different methylation levels of genes involved in neuroprotection and neuronal growth. 64, 65 In pheripheral samples of living patients a different level of methylation in neuronal plasticity genes has also been suggested. 66 These data are similar to those derived from animal studies, supporting an early-life environmental role in regulating genes related to neuronal plasticity. One of them is the gene coding BDNF. In female rodents stressed by introduction into a new environment with inadequate bedding material, the expression of BDNF gene was decreased in prefrontal cortex due to hyper-methylation of BDNF promoter gene. 67 Similar effects were found in the dorsal hippocampus in a post-traumatic stress disorder adult rat model. 68 In vivo studies on suicide completers showed that they have higher levels of methylation in the Wernicke area than HC. This higher methylation was associated with lower BDNF expression. In line with these data, some studies reported differential methylation of BDNF promoter in pheripheral samples of depressed living patients. [69] [70] [71] [72] 
Discussion
The aim of this review is to investigate the relationship between inflammatory markers in depressed patients with or without suicidal attempts and suicidal ideation, compared to HC (Table 1) . Studies have been divided into three classes: in vivo, in vitro and postmortem. In each class, when it was possible, studies have been subdivided in: suicidal versus non-suicidal depressed patients and suicidal depressed patients versus HC (for recent systematic reviews and meta-analyses see Serafini et al., 73 Ducasse et al. 74 and Black and Miller 75 ).
In vivo studies
When suicidal depressed patients were compared to non-suicidal depressed patiens, no significant differences in IL-4, IFN-γ and TGF-1β plasma concentrations were found by Gabbay et al. 93 Contrasting results were reported for TNF-α plasma levels. 76, 94 O'Donovan 95 found higher IL-6 and CRP plasma levels in patients with higher suicidal ideation than in patients with less suicidal thoughts. A non-significant trend was found for IL-10. 78 Decreased IL-2 plasma concentrations were reported in one study. 78 Increased plasma levels 77 and non-significant group differences 76 were found for IL-6.
Janelidze et al. 77 found increased TNF-α plasma levels in suicidal patients compared to HC. No significant groups differences were reported for TNF-α plasma 76, 78 and CSF 96 concentrations. No significant groups differences were reported for IL-4, 76 TGF-1β 76, 78 plasma levels and IL-1β 79 CSF levels. Regarding IL-6, two authors reported no Isung et al. 40 43 suicide attempters, 20 controls
IL-8, VEGF
In vivo CSF MADRS, SCID Lower CSF VEGF and IL-8 levels in suicide attempters than controls.
A more severe depressive state was correlated with low CSF levels of VEGF.
Vargas et al. 98 150 patients with a history of suicide attempts, 201 without suicide attempts IL-6, TNF-α, CRP, fibrinogen, ERS
In vivo serum SCID, ASSIST, self-reported questionnaire for smoking status and lifetime suicidal behavior information No significant differences between both groups in CRP, fibrinogen, ERS, IL-6 and TNF-α.
O'Donovan et al. 95 76 depressed patient, 48 controls IL-6, IL-10, TNF-α, TGF-1β, CRP
In vivo plasma HDRS, MINI In our sample, patients with MDD who had high levels of suicidal ideation showed significantly elevated IL-6 and CRP levels in high suicidal depressed patients than in low suicidal depressed patients. Only those patients with high levels of suicidal ideation exhibited significantly higher levels of inflammation than controls.
Janelidze et al. 97 206 suicide attempters, 578 controls
IL-8
In vivo CSF and plasma SCID, CPRS, MADRS, BSA Significantly lower of IL-8 plasma and CSF levels in suicide attempters with anxiety than in controls. IL-8 plasma and CSF levels correlated negatively with symptoms of anxiety.
Mendlovic et al. 102 significant differences between groups in plasma 76 and CSF concentrations. 40 Three authors found increased IL-6 plasma 77, 78 and CSF 79 levels. Increased IFN-γ 76 and IL-10 plasma levels were reported. 78 Lower concentrations were reported for plasma IL-2 77 and CSF VEGF 80 levels. CSF IL-8 concentrations were lower 80 or non-significant. 79 In particular, Janelidze et al. 97 found lower CSF and plasma IL-8 concentrations in suicidal attempters with anxiety. Finally, Vargas et al. 98 reported no significant differences between patients with and without a history of suicide in CRP, fibrinogen, erythrocyte sedimentation rate (ERS), IL-6 and TNF-α. Some authors reported correlations between cytokine levels and psychopathological scales scores. A positive correlation between Montgomery Asberg Depression Rating Scale (MADRS) 81 scores and CSF IL-6 levels was highlighted in all patients. 79 In particular, violent suicidal attempters showed the highest IL-6 levels. 79 Significant negative correlations between CSF VEGF levels and MADRS scores, and non-significant correlations between CSF IL-8 and MADRS scores were found by Isung et al. 80 Some longitudinal studies reported data about VEGF, IL-2, IFN-γ and TNF-α levels. Suicidal patients who completed suicide had lower VEGF levels than suicidal attempters, but only a trend for lower IL-2 and IFN-γ levels was found. 99 Plasma TNF-α levels were significantly decreased, in responder patients treated with venlafaxine. The reduction in TNF-α levels was positively related to the reduction in Hamilton Depression Rating Scale (HDRS) 88 scores. 100 Nassberger and Traskman-Bendz 101 found high levels of soluble IL-2 receptor concentration at follow-up in medication-free suicidal attempters.
In vitro studies
Suicidal depressed patients secreted less IL-4, IL-5, 102 IL-2 and IL-6 103 than non-suicidal depressed patients.
The in vitro TGF-1β production was significantly higher in depressed patients, both with and without attempted suicide, than in HC, 88, 104 but no statistically significant differences were reported by Lee and Kim. 105 Stimulated lymphocytes of suicidal depressed patients secreted significantly more IFN-γ, 87 IL-12 90 and IL-6 88 than those of HC. A lower production of IFN-γ and IL-4 in depressed patients, with or without attempted suicide, compared to HC were reported by Kim et al. 88 Studies reported different correlations between cytokine concentrations and psychopathological scales scores: positive correlations among IL-6, IFN-γ and HDRS scores; 88 negative correlations between IL-4 and HDRS scores; 88 no correlations between IL-2 or TGF-1β levels and HDRS or Brief Psychiatry Rating Scale (BPRS) 89 scores. 90 
Postmortem studies
In post-mortem studies, [106] [107] [108] authors demonstrated associations between inflammatory cytokines and patients dead by suicide (even if most authors, except for Pandey et al., did not report whether patients were depressed or not), when compared to HC. Levels of IL-1β, IL-6 (in adolescents), 92 IL-4 (in women) and IL-13 (in men) 94 were significantly increased in postmortem brain samples of suicide victims compared to those of HC. 93 TNF-α levels resulted also significantly increased, except for Tonelli et al. 94 For a final summary see Table 2 .
Conclusions
In the past few years, a number of studies have been performed in order to identify a biological marker associated with suicidal depressed patients. This review summarises the studies investigating the relationship between inflammatory markers in depressed patients, with or without suicidal attempts and suicidal ideation, in comparison to healthy controls. More studies have been conducted under in vivo than in vitro and in postmortem conditions. Some, but limited, data reported correlations between cytokine levels and psychopathological scales scores. Insufficient and contrasting data are available in literature so far. For these reasons, furher investigations are needed. No significant differences 23, 25 No significant differences 39 No significant differences 26 
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